Assertio Holdings (ASRT) Operating Margin (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Operating Margin came in at 185.95% in Q1 2026, down 13599.0% year-on-year from N/an in Q1 2025, and down 114.32% quarter-over-quarter from 86.76% in Q4 2025.
Assertio Holdings (ASRT) Operating Margin (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Operating Margin across 8 years of filings, most recently posting 185.95% for Q1 2026.
- Operating Margin for Q1 2026 came in at 185.95%, down 13599.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.21% (up 183.0% YoY), and the FY2025 annual result was 18.14%, up 145.0% from the prior year.
- Operating Margin came in at 185.95% for Q1 2026 at Assertio Holdings, down from 86.76% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 31.64% in Q1 2022 to a low of 640.72% in Q3 2023.
- The 5-year median for Operating Margin is 11.62% (2024), against an average of 58.79%.
- Across the five-year window, Operating Margin slumped 65953 bps in 2023 and soared 63029 bps in 2024, its largest moves.
- Assertio Holdings' Operating Margin stood at 21.1% in 2022, then tumbled by 565 bps to 98.01% in 2023, then surged by 57 bps to 41.87% in 2024, then tumbled by 107 bps to 86.76% in 2025, then plunged by 114 bps to 185.95% in 2026.
- The last three Operating Margin figures came in at 185.95% (Q1 2026), 86.76% (Q4 2025), and 23.21% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -185.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -185.95% |
| Dec 31, 2025 | -86.76% |
| Sep 30, 2025 | 23.21% |
| Jun 30, 2025 | -27.50% |
| Mar 31, 2025 | -49.96% |
| Dec 31, 2024 | -41.87% |
| Sep 30, 2024 | -10.44% |
| Jun 30, 2024 | -11.62% |
| Mar 31, 2024 | -13.37% |
| Dec 31, 2023 | -98.01% |
| Sep 30, 2023 | -640.72% |
| Jun 30, 2023 | 30.30% |
| Mar 31, 2023 | 10.94% |
| Dec 31, 2022 | 21.10% |
| Sep 30, 2022 | 18.81% |
| Jun 30, 2022 | 30.72% |
| Mar 31, 2022 | 31.64% |
| Dec 31, 2021 | 23.95% |
| Sep 30, 2021 | 23.30% |
| Jun 30, 2021 | -47.30% |